Now Even The COMMON COLD is Being Counted As A Positive COVID-19 Result, CDC Says

Follow us on social media

The Center for Disease Control and Prevention (CDC) is essentially setting policy across the country, endlessly putting out a stream of so-called facts (that they then revise or rescind).


Their latest update on COVID-19, posted on Tuesday, is a real doozy. Here’s what the CDC said in a section headlined: What do your results mean?

A positive test result shows you may have antibodies from an infection with the virus that causes COVID-19. However, there is a chance a positive result means that you have antibodies from an infection with a virus from the same family of viruses (called coronaviruses), such as the one that causes the common cold.”

That’s right, because COVID-19 is a coronavirus (like the common cold), your positive test means you have COVID-19 (or the common cold).

Coronaviruses (CoV) — called that because they have spikes around a central ball that looks like the sun — are part of a large family of viruses that cause illness ranging from a cold to more severe diseases, including COVID-19 (caused by SARS-CoV-2), and others such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV).
SARS -CoV-2 is also known as a novel coronavirus (nCoV) because it is a new strain that has not been previously identified in humans.


J.B. Neiman, a managing partner and general counsel of a Texas-based health care company that owns 13 free-standing clinics, has an idea. He told former New York Times reporter Alex Berenson, who has been on the forefront of covering the facts behind COVID-19, that the bottom line is money.


The mainstream media is breathlessly reporting a spike in new infections (even though we’re all wearing masks, so how’d that happen?).Neiman told Berenson he has “heard several stories of how discharge planners are being pressured to put Covid as primary diagnosis — as that pays significantly better.


Hospitals want to avoid the discussion but if they don’t they risk another shutdown. This may be an explanation for why there is a gap in hospital executives saying they have plenty of capacity and the increasing number of Covid hospitalizations.


https://www.thegatewaypundit.com/2020/07/now-even-common-cold-counted

Related Articles

COVID Reference

Six weeks after the third edition, the world has changed again.
The pandemic is raging in South America, particularly in Brazil,
Ecuador and Peru. SARS-CoV-2 is under control in China, but in
Iran it is not. And in Europe, where most countries have weathered
the first wave and open borders to save a compromised tourist season, is now wondering if and for how long this biological
drôle de guerre could last.

Science has moved ahead, too. We have seen a more complex
picture of COVID-19 and new clinical syndromes; the first data
from vaccine trials; first results from randomized controlled
drug studies; encouraging publications on monoclonal neutralizing antibodies and serological evidence about the number of people who have come into contact with SARS-CoV-2. Unfortunately, we have also seen the first science scandal with fake data published in highly ranked journals. And we face new challenges like long-term effects of COVID-19 and a Kawasaki-like inflammatory multisystem syndrome in children.

For quite some time, prevention will continue to be the primary
pillar of pandemic control. In future waves of the SARS-CoV-2
pandemic, we will focus on the conditions under which SARSCoV-
2 is best transmitted: crowded, closed (and noisy) places and
spaces. Although hospitals are not noisy, they are crowded and
closed, and the battle against the new coronavirus will be decided
at the very center of our healthcare system. Over the next
months and maybe years, one of all of our top priorities will be
to give all healthcare workers and patients perfect personal protective equipment.

The HPV Vaccine: An Ethical Dilemma

In 2014 there were numerous reports of mass hysteria and mystery illnesses spreading around the small town of El Carmen De Bolivar, Colombia. According to an article published by CBS, there was a steady increase of young women being hospitalized in this small town, all of which reported the same symptoms of fainting, numbness and tingling of the hands and feet, and headaches. Speculations about the Gardasil vaccination arose, but were disregarded by the mayor of the town stating that “there is no evidence the vaccine, which has undergone extensive testing and regulation is to blame” (CBS, 2014). According to this statement, he is not necessarily wrong, because the clinical trials of this vaccine have been proven to have misleading conclusions due to errors in the study design.

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic containment measures, the spread of this virus is ongoing. SARS-CoV-2 is the aetiological agent of coronavirus disease 2019 (COVID-19) characterised by pulmonary infection in humans. The efforts of international health authorities have since focused on rapid diagnosis and isolation of patients as well as the search for therapies able to counter the most severe effects of the disease. In the absence of a known efficient therapy and because of the situation of a public health emergency, it made sense to investigate the possible effect of chloroquine/hydroxychloroquine against SARS-CoV-2 since this molecule was previously described as a potent inhibitor of most coronaviruses, including SARS-CoV-1. Preliminary trials of chloroquine repurposing in the treatment of COVID- 19 in China have been encouraging, leading to several new trials. Here we discuss the possible mechanisms of chloroquine interference with the SARS-CoV-2 replication cycle.

Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial

Despite our small number of cases, the potential of HCQ in the treatment of COVID-19 has been partially confirmed. Considering that there is no better option at present, it is a promising practice to apply HCQ to COVID-19 under reasonable management. However, Large-scale clinical and basic research is still needed to clarify its specific mechanism and to continuously optimize the treatment plan.

Responses